Levilimab Usage And Synthesis

Uses

Levilimab (BCD-089) is a fully humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody. Levilimab is an inflammation-alleviating antibody. Levilimab can be used for the research of rheumatoid[1].

References

[1] Pum A, et al. Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm. Biomolecules. 2021 Jan 12;11(1):91. DOI:10.3390/biom11010091

Levilimab(2035008-70-7)Related Product Information

• Gremubamab
• clenoliximab
• Praluzatamab
• Quisovalimab
• Teclistamab
• Vadastuximab
• Pozelimab
• Lorigerlimab
• Amivantamab
• Mazorelvimab